Efficacy and Safety of Continuous Subcutaneous Infusion of Recombinant Human Gonadotropins for Congenital Micropenis during Early Infancy


Publisher： Karger

E-ISSN： 1663-2826|87|2|103-110

ISSN： 1663-2818

Source： Hormone Research in Paediatrics, Vol.87, Iss.2, 2017-01, pp. : 103-110

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selection for and Initiation of Continuous Subcutaneous Insulin Infusion

By  

Hormone Research in Paediatrics, Vol. 57, Iss. 1, 2004-11 ,pp. : 101-104

Karger

Access to resources Recommend Favorite

Special Management of Insulin Lispro in Continuous Subcutaneous Insulin Infusion in Young Diabetic Children: A Randomized Cross-Over Study

By  

Hormone Research in Paediatrics, Vol. 62, Iss. 6, 2004-12 ,pp. : 265-271

Karger

Access to resources Recommend Favorite

Seven Years of Safety and Efficacy of the Recombinant Human Growth Hormone Omnitrope® in the Treatment of Growth Hormone Deficient Children: Results of a Phase III Study

By  

Hormone Research in Paediatrics, Vol. 72, Iss. 6, 2009-10 ,pp. : 359-369

Karger

Access to resources Recommend Favorite

Safety of High Doses of Recombinant Human Growth Hormone

By  

Hormone Research in Paediatrics, Vol. 49, Iss. 2, 2004-11 ,pp. : 78-81

Karger

Access to resources Recommend Favorite

Three Cases of Congenital Growth Hormone Deficiency with Micropenis and Hypospadias: What Does Growth Hormone Have to Do with It?

By  

Hormone Research in Paediatrics, Vol. 51, Iss. 2, 1999-06 ,pp. : 101-104

Karger

Access to resources Recommend Favorite